Notably, ALS had significantly higher serum NFL levels compared with the UMN diseases primary lateral sclerosis (PLS) and hereditary spastic paraparesis (HSP), while the differences between ALS and the LMN disease progressive muscular atrophy (PMA), CIDP, and GBS did not reach statistical significance. This evidence concerns the gene PMP22 and hereditary spastic paraplegia.